Boards:
Quotes:
Favorites
Hot
Monitor
Movers
Level 2
NewsWire
Menu
Boards
Stocks
Commodities
Forex
Cryptocurrency
The Lounge
News
InvestorsHub Newswire
All Company News
iHub Market News
News Scanner
Price and News Alerts
Investorshub Daily
Newsletters
Market Data
Monitor
Level 2
Live Charts
Trades
Portfolio
Economic Calendar
Follow Feed
Trader Alerts
Price Alerts
Markets
Crypto
Forex
Commodities
Futures
Discover
Market Movers
Options Flow
Advanced Search
Breakout Boards
Most Read
Most Posted
Most Followed Members
Active Boards
New Boards
Site Stats
PostStream
My Stocks Activity
Ticker Buzz Cloud
Subscribe
Login/Register
Support
1-888-992-3836
help@advfn.com
S&P 500
4,229.45
(
-1.37%
)
US Tech 100
14,184.00
(
-1.84%
)
Dow Jones
33,002.38
(
-1.29%
)
Brent Oil
90.725
(
0.59%
)
Bitcoin
27,469.33
(
-0.20%
)
Home
Investing
Stocks
USA
NASDAQ
Coeptis Therapeutics Holdings Inc
(COEP)
Coeptis Therapeutics Holdings Inc
(COEP)
News
News
News Scanner
Streaming News
Highlight Phrases
COEP
Coeptis Therapeutics (COEP)
Coeptis Therapeutics Holdings Inc
Date:
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
Regulatory News
Text Search:
Sort by:
newest to oldest
oldest to newest
Non-Regulatory News
Showing the most relevant articles for your search:
NASDAQ:COEP
1
Date
Time
Source
Headline
Symbol
Company
10/03/2023
12:50PM
iHub Newswire
Featured
Cannabix's MSBS Marijuana Breathalyzer Technology Advances Quantification of THC in Breath
09/27/2023
7:30AM
PR Newswire (US)
Coeptis Therapeutics to Present at the 2023 Cell & Gene Meeting on the Mesa
NASDAQ:COEP
Coeptis Therapeutics Holdings Inc
09/14/2023
7:30AM
PR Newswire (US)
Coeptis Therapeutics Provides Safety and Dosing Update from Phase 1 Trials Investigating DVX201 in Relapsed/Refractory AML or High Risk MDS and Hospitalized COVID-19 Infection
NASDAQ:COEP
Coeptis Therapeutics Holdings Inc
09/11/2023
7:30AM
PR Newswire (US)
Coeptis Therapeutics Announces Deverra Therapeutics Has Received Two Life Science Start-Up and Development Awards and Associated Grant from Washington's Cancer Research Endowment
NASDAQ:COEP
Coeptis Therapeutics Holdings Inc
08/30/2023
1:00PM
PR Newswire (US)
Coeptis Therapeutics Appoints Colleen Delaney, MD, as Chief Scientific and Medical Officer
NASDAQ:COEP
Coeptis Therapeutics Holdings Inc
08/17/2023
7:30AM
PR Newswire (US)
Coeptis Therapeutics Completes Exclusive License for Allogeneic Immuno-Oncology Platform and Clinical Stage Assets from Deverra Therapeutics
NASDAQ:COEP
Coeptis Therapeutics Holdings Inc
08/01/2023
8:00AM
PR Newswire (US)
Coeptis Therapeutics Files FDA 513(g) Submission for CD38 In Vitro Companion Diagnostic
NASDAQ:COEP
Coeptis Therapeutics Holdings Inc
06/16/2023
4:00PM
PR Newswire (US)
Coeptis Therapeutics Holdings, Inc. Announces Closing of $3.5 Million Underwritten Offering
NASDAQ:COEP
Coeptis Therapeutics Holdings Inc
06/14/2023
9:28AM
PR Newswire (US)
Coeptis Therapeutics Holdings, Inc. Announces Pricing of $3.5 Million Underwritten Offering
NASDAQ:COEP
Coeptis Therapeutics Holdings Inc
06/09/2023
7:00AM
PR Newswire (US)
Coeptis Therapeutics Receives Approval to Transfer to The Nasdaq Capital Market
NASDAQ:COEP
Coeptis Therapeutics Holdings Inc
05/17/2023
8:30AM
PR Newswire (US)
Coeptis Therapeutics Appoints Brian Cogley as Chief Financial Officer
NASDAQ:COEP
Coeptis Therapeutics Holdings Inc
05/10/2023
3:00PM
PR Newswire (US)
Coeptis Therapeutics' SNAP-CAR Technology Platform for Programmable Antigen Targeting Featured in Peer-Reviewed Article in Nature Communications
NASDAQ:COEP
Coeptis Therapeutics Holdings Inc
04/18/2023
7:30AM
PR Newswire (US)
Coeptis Therapeutics Signs Agreement to Acquire Allogeneic Immuno-Oncology NK Platform in Phase 1 Clinical Trials from Deverra Therapeutics
NASDAQ:COEP
Coeptis Therapeutics Holdings Inc
03/29/2023
9:45AM
PR Newswire (US)
Coeptis Therapeutics Secures Exclusive Rights to Negotiate to Acquire Transformational Cell Therapy Platform to Enable Potent Combinatorial Immuno-Oncology Treatment Strategies
NASDAQ:COEP
Coeptis Therapeutics Holdings Inc
03/21/2023
7:00AM
PR Newswire (US)
Coeptis Therapeutics' SNAP-CAR Technology Platform Highlighted in Peer-Reviewed Article in Translational Medicine
NASDAQ:COEP
Coeptis Therapeutics Holdings Inc
02/07/2023
8:00AM
PR Newswire (US)
Coeptis Therapeutics and ShareIntel Enter Shareholder Service Agreement, Targeting Illegal Short Selling
NASDAQ:COEP
Coeptis Therapeutics Holdings Inc
01/31/2023
8:45AM
PR Newswire (US)
Coeptis Therapeutics Enters into Sponsored Research Agreement with the University of Pittsburgh to Advance SNAP-CAR Development Program
NASDAQ:COEP
Coeptis Therapeutics Holdings Inc
11/22/2022
7:00AM
PR Newswire (US)
Coeptis Therapeutics Engages IQVIA to Support SNAP-CAR Development Program
NASDAQ:COEP
Coeptis Therapeutics Holdings Inc
11/15/2022
7:00AM
PR Newswire (US)
Coeptis Therapeutics Holdings to Ring the Nasdaq Stock Market Opening Bell
NASDAQ:COEP
Coeptis Therapeutics Holdings Inc
11/08/2022
7:00AM
PR Newswire (US)
Coeptis Therapeutics' Scientific Advisory Board Members Featured on "Biology of Natural Killer (NK) Cells" Podcast
NASDAQ:COEP
Coeptis Therapeutics Holdings Inc
Showing the most relevant articles for your search:
NASDAQ:COEP
1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.
Register now
to create your own custom streaming stock watchlist.
Log in to InvestorsHub
Register Now